Ishara Investments LP

Ishara Investments LP reported 41 holdings worth US$121M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Ishara Investments LP reported 41 holdings worth US$121M as of Sep 30, 2026. Largest: Travere Therapeutics, Inc., Cytokinetics, Incorporated and BridgeBio Pharma, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
41
Value as reported
US$121M

The filing in full

CompanySharesValue as reported% of portfolio
Travere Therapeutics, Inc.145KUS$8.54M7.1%
Cytokinetics, Incorporated128KUS$8.44M7.0%
BridgeBio Pharma, Inc.100KUS$6.58M5.4%
ACADIA Pharmaceuticals Inc.320KUS$6.45M5.3%
Tarsus Pharmaceuticals, Inc.70,000US$5.5M4.5%
PTC Therapeutics, Inc.80,000US$5.18M4.3%
Praxis Precision Medicines, Inc.17,000US$4.95M4.1%
Vera Therapeutics, Inc.150KUS$4.84M4.0%
Arcutis Biotherapeutics, Inc.180KUS$4.76M3.9%
Annexon, Inc.1.12MUS$4.74M3.9%
United Therapeutics Corporation8,000US$4.34M3.6%
Xeris Biopharma Holdings, Inc.400KUS$3.82M3.2%
Celcuity Inc.48,000US$3.82M3.2%
DBV Technologies SA270KUS$3.18M2.6%
Viridian Therapeutics, Inc.150KUS$3.09M2.6%
Zentalis Pharmaceuticals, Inc.1.08MUS$2.99M2.5%
BioMarin Pharmaceutical Inc.48,000US$2.88M2.4%
Biogen Inc.12,000US$2.71M2.2%
Mineralys Therapeutics, Inc.100KUS$2.51M2.1%
Ligand Pharmaceuticals Incorporated8,000US$2.5M2.1%
Ultragenyx Pharmaceutical Inc.160KUS$2.4M2.0%
Vaxcyte, Inc.40,000US$2.28M1.9%
ORIC Pharmaceuticals, Inc.160KUS$2.16M1.8%
Axsome Therapeutics, Inc.10,000US$1.84M1.5%
Silence Therapeutics PLC160KUS$1.75M1.4%
Beam Therapeutics Inc.70,000US$1.71M1.4%
Biohaven Ltd.120KUS$1.6M1.3%
Contineum Therapeutics, Inc.108KUS$1.45M1.2%
Genmab A/S40,000US$1.43M1.2%
Neurocrine Biosciences, Inc.8,000US$1.13M0.94%
Monopar Therapeutics Inc.12,000US$956K0.79%
ARS Pharmaceuticals, Inc.200KUS$862K0.71%
Ionis Pharmaceuticals, Inc.16,000US$714K0.59%
Olema Pharmaceuticals, Inc.80,000US$691K0.57%
Lexicon Pharmaceuticals, Inc.320KUS$600K0.50%
Savara, Inc.80,000US$413K0.34%
Erasca, Inc.0US$00.00%
Gossamer Bio, Inc.0US$00.00%
Insmed Incorporated0US$00.00%
Kura Oncology, Inc.0US$00.00%
Nektar Therapeutics0US$00.00%
Nuvation Bio Inc.0US$00.00%
Scholar Rock Holding Corporation0US$00.00%
Sionna Therapeutics, Inc.0US$00.00%
Tonix Pharmaceuticals Holding Corp.0US$00.00%
Vertex Pharmaceuticals Incorporated0US$00.00%
Agios Pharmaceuticals, Inc.0US$00.00%
Alnylam Pharmaceuticals, Inc.0US$00.00%
Crinetics Pharmaceuticals, Inc.0US$00.00%
Enliven Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related